Orexigen™ Therapeutics, Inc. (Nasdaq:OREX), a biopharmaceutical company focused on the treatment of central nervous system (CNS) disorders including obesity, will announce its third quarter 2007 financial results on Thursday, November 8, 2007 after the markets close. The announcement will be followed by a live webcast and conference call at 2:00 p.m. Pacific Daylight Time.
